Table 2. Data on Women With FIGO Stage I or II Endometrial Cancer Who Experienced Severe Complications Before (Group 1) or After (Group 2) Introduction of MIRS.
| Characteristic | Women, No. (%) [95% CI] | |||||
|---|---|---|---|---|---|---|
| MIS Group 1 (n = 436) | MIS Group 2 (n = 1851) | TAH Group 1 (n = 2655) | TAH Group 2 (n = 712) | Overall Group 1 (n = 3091) | Overall Group 2 (n = 2563) | |
| 30-d Mortality | 0 | 2 (0.1) [0.0-0.4] | 9 (0.3) [0.2-0.6] | 5 (0.7) [0.2-1.6] | 9 (0.3) [0.1-0.6] | 7 (0.3) [0.1-0.6] |
| Intraoperative complicationsa | 0 | 9 (0.5) [0.2-0.9] | 6 (0.2) [0.1-0.5] | 2 (0.3) [0.0-1.0] | 6 (0.2) [0.1-0.4] | 11 (0.4) [0.2-0.8] |
| 90-d Postoperative complicationsa | 24 (5.5) [3.6-8.1] | 72 (3.9) [3.1-4.8] | 189 (7.1) [6.2-8.2] | 75 (10.5) [8.4-13.0] | 213 (6.9) [6.0-7.8] | 147 (5.7) [4.9-6.7] |
| Any complicationsa | 24 (5.5) [3.6-8.1] | 79 (4.3) [3.4-5.3] | 202 (7.6) [6.6-8.7] | 81 (11.4) [9.1-13.9] | 226 (7.3) [6.4-8.3] | 160 (6.2) [5.3-7.2] |
Abbreviations: FIGO, International Federation of Obstetrics and Gynecology; MIRS, minimally invasive robotic surgery; MIS, minimally invasive surgery; TAH, total abdominal hysterectomy.
a
Each woman who experienced 1 or several complications was registered once.